Miaoli, Taiwan

Seong Jin Yu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Advanced Protein Technologies Corporation. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seong Jin Yu: Innovator in Dopamine-Related Therapeutics

Introduction

Seong Jin Yu is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of medical science, particularly in the area of dopamine-related diseases. His innovative work focuses on developing compositions that can ameliorate, prevent, or treat conditions associated with reduced dopamine levels.

Latest Patents

Seong Jin Yu holds a patent for a composition containing 2'-fucosyllactose (2'-FL) aimed at addressing diseases caused by a reduction of dopamine. This patent is particularly relevant for its application in preventing and treating Parkinson's disease. The composition effectively suppresses the degeneration of dopaminergic neurons, thereby improving motor activity in affected individuals. His patent is a testament to the potential of 2'-FL in therapeutic applications.

Career Highlights

Throughout his career, Seong Jin Yu has been associated with Advanced Protein Technologies Corporation. His work at this company has allowed him to focus on innovative solutions for health issues related to dopamine deficiency. His research has garnered attention for its potential impact on treating neurodegenerative diseases.

Collaborations

Seong Jin Yu has collaborated with notable colleagues, including Kuo Jen Wu and Chul Soo Shin. These partnerships have contributed to the advancement of research in the field of dopamine-related therapeutics.

Conclusion

Seong Jin Yu's contributions to the field of medical science, particularly through his patent on 2'-FL, highlight his role as an innovator in addressing dopamine-related diseases. His work continues to pave the way for new therapeutic approaches that could significantly improve the quality of life for individuals suffering from such conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…